Alvotech (ALVO)
12.40
-0.02
(-0.16%)
USD |
NASDAQ |
Nov 21, 16:00
12.40
0.00 (0.00%)
After-Hours: 20:00
Alvotech Debt to Equity Ratio: -2.991 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | -2.991 |
| June 30, 2024 | -1.743 |
| March 31, 2024 | -1.485 |
| December 31, 2023 | -1.030 |
| September 30, 2023 | -1.380 |
| June 30, 2023 | -1.690 |
| Date | Value |
|---|---|
| March 31, 2023 | -1.210 |
| December 31, 2022 | -1.355 |
| September 30, 2022 | -1.871 |
| June 30, 2022 | -1.887 |
| March 31, 2022 | |
| December 31, 2021 | -2.956 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-2.991
Minimum
Sep 2024
-1.030
Maximum
Dec 2023
-1.782
Average
-1.690
Median
Jun 2023
Debt to Equity Ratio Benchmarks
| Procaps Group SA | -- |
| Johnson & Johnson | 0.5096 |
| Pfizer Inc | 0.7219 |
| Rigel Pharmaceuticals Inc | -4.083 |
| NovaBay Pharmaceuticals Inc | 0.0476 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.233B |
| Total Liabilities (Quarterly) | 1.577B |
| Shareholders Equity (Quarterly) | -343.71M |
| Current Ratio | 2.694 |
| Net Debt Paydown Yield | -1.22% |